nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CALM1—trigeminal nerve—pharynx cancer	0.0649	0.0788	CbGeAlD
Pimozide—HRH1—nose—pharynx cancer	0.0603	0.0733	CbGeAlD
Pimozide—CALM1—cranial nerve—pharynx cancer	0.0462	0.0562	CbGeAlD
Pimozide—HTR2A—trigeminal nerve—pharynx cancer	0.0395	0.048	CbGeAlD
Pimozide—CALM2—ear—pharynx cancer	0.0378	0.0459	CbGeAlD
Pimozide—CALM1—ear—pharynx cancer	0.0376	0.0457	CbGeAlD
Pimozide—HTR2A—vagus nerve—pharynx cancer	0.037	0.0449	CbGeAlD
Pimozide—HTR2A—cranial nerve—pharynx cancer	0.0282	0.0342	CbGeAlD
Pimozide—CACNA1G—head—pharynx cancer	0.0172	0.0209	CbGeAlD
Pimozide—CALM2—mouth—pharynx cancer	0.0156	0.019	CbGeAlD
Pimozide—CALM1—mouth—pharynx cancer	0.0156	0.0189	CbGeAlD
Pimozide—OPRM1—brainstem—pharynx cancer	0.0141	0.0171	CbGeAlD
Pimozide—CALM3—parotid gland—pharynx cancer	0.0139	0.0168	CbGeAlD
Pimozide—CALM2—neck—pharynx cancer	0.0134	0.0162	CbGeAlD
Pimozide—CALM1—neck—pharynx cancer	0.0133	0.0162	CbGeAlD
Pimozide—CALM3—saliva-secreting gland—pharynx cancer	0.0133	0.0161	CbGeAlD
Pimozide—DRD3—head—pharynx cancer	0.0123	0.0149	CbGeAlD
Pimozide—HTR6—head—pharynx cancer	0.0118	0.0144	CbGeAlD
Pimozide—OPRK1—head—pharynx cancer	0.0109	0.0133	CbGeAlD
Pimozide—CALM2—parotid gland—pharynx cancer	0.0109	0.0132	CbGeAlD
Pimozide—CYP2E1—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0106	0.0601	CbGpPWpGaD
Pimozide—CALM2—saliva-secreting gland—pharynx cancer	0.0104	0.0127	CbGeAlD
Pimozide—HTR1A—brainstem—pharynx cancer	0.0104	0.0126	CbGeAlD
Pimozide—CALM1—saliva-secreting gland—pharynx cancer	0.0104	0.0126	CbGeAlD
Pimozide—CALM3—trachea—pharynx cancer	0.0102	0.0124	CbGeAlD
Pimozide—CALM2—brainstem—pharynx cancer	0.0102	0.0124	CbGeAlD
Pimozide—CALM1—brainstem—pharynx cancer	0.0102	0.0124	CbGeAlD
Pimozide—DRD2—brainstem—pharynx cancer	0.00939	0.0114	CbGeAlD
Pimozide—CYP2E1—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.00932	0.0527	CbGpPWpGaD
Pimozide—CALM2—epithelium—pharynx cancer	0.0091	0.0111	CbGeAlD
Pimozide—CALM1—epithelium—pharynx cancer	0.00906	0.011	CbGeAlD
Pimozide—OPRM1—spinal cord—pharynx cancer	0.00875	0.0106	CbGeAlD
Pimozide—HTR2A—neck—pharynx cancer	0.00811	0.00985	CbGeAlD
Pimozide—CALM3—spinal cord—pharynx cancer	0.00809	0.00983	CbGeAlD
Pimozide—CALM2—trachea—pharynx cancer	0.00805	0.00978	CbGeAlD
Pimozide—CALM1—trachea—pharynx cancer	0.00801	0.00973	CbGeAlD
Pimozide—OPRM1—head—pharynx cancer	0.00778	0.00945	CbGeAlD
Pimozide—CYP2D6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.00754	0.0426	CbGpPWpGaD
Pimozide—CHRM2—head—pharynx cancer	0.00708	0.0086	CbGeAlD
Pimozide—CALM2—lymphoid tissue—pharynx cancer	0.00701	0.00851	CbGeAlD
Pimozide—CALM1—lymphoid tissue—pharynx cancer	0.00698	0.00848	CbGeAlD
Pimozide—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.00661	0.0374	CbGpPWpGaD
Pimozide—HRH1—epithelium—pharynx cancer	0.00661	0.00803	CbGeAlD
Pimozide—HTR1A—spinal cord—pharynx cancer	0.00646	0.00785	CbGeAlD
Pimozide—CYP1A2—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.00639	0.0361	CbGpPWpGaD
Pimozide—CALM2—spinal cord—pharynx cancer	0.00635	0.00772	CbGeAlD
Pimozide—CALM1—spinal cord—pharynx cancer	0.00632	0.00768	CbGeAlD
Pimozide—HTR2A—brainstem—pharynx cancer	0.0062	0.00753	CbGeAlD
Pimozide—HRH1—trachea—pharynx cancer	0.00584	0.0071	CbGeAlD
Pimozide—KCNH2—spinal cord—pharynx cancer	0.00576	0.00699	CbGeAlD
Pimozide—HTR1A—head—pharynx cancer	0.00575	0.00698	CbGeAlD
Pimozide—CALM2—head—pharynx cancer	0.00565	0.00686	CbGeAlD
Pimozide—CYP2D6—brainstem—pharynx cancer	0.00564	0.00686	CbGeAlD
Pimozide—CALM1—head—pharynx cancer	0.00562	0.00683	CbGeAlD
Pimozide—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0056	0.0317	CbGpPWpGaD
Pimozide—HTR2A—epithelium—pharynx cancer	0.00552	0.0067	CbGeAlD
Pimozide—DRD2—head—pharynx cancer	0.00519	0.00631	CbGeAlD
Pimozide—KCNH2—head—pharynx cancer	0.00511	0.00621	CbGeAlD
Pimozide—CALM3—lymph node—pharynx cancer	0.00503	0.00612	CbGeAlD
Pimozide—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.00493	0.0279	CbGpPWpGaD
Pimozide—CYP2E1—lymphoid tissue—pharynx cancer	0.00489	0.00594	CbGeAlD
Pimozide—HTR2A—trachea—pharynx cancer	0.00488	0.00593	CbGeAlD
Pimozide—CYP2E1—spinal cord—pharynx cancer	0.00443	0.00539	CbGeAlD
Pimozide—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.00432	0.0244	CbGpPWpGaD
Pimozide—CYP3A7—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00413	0.0233	CbGpPWpGaD
Pimozide—HRH1—head—pharynx cancer	0.0041	0.00498	CbGeAlD
Pimozide—CALM2—lymph node—pharynx cancer	0.00395	0.0048	CbGeAlD
Pimozide—CYP2E1—head—pharynx cancer	0.00394	0.00479	CbGeAlD
Pimozide—CALM1—lymph node—pharynx cancer	0.00394	0.00478	CbGeAlD
Pimozide—HTR2A—spinal cord—pharynx cancer	0.00385	0.00468	CbGeAlD
Pimozide—CYP3A7—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00362	0.0205	CbGpPWpGaD
Pimozide—ABCB1—epithelium—pharynx cancer	0.00362	0.00439	CbGeAlD
Pimozide—KCNH2—lymph node—pharynx cancer	0.00358	0.00435	CbGeAlD
Pimozide—HTR2A—head—pharynx cancer	0.00342	0.00416	CbGeAlD
Pimozide—ABCB1—trachea—pharynx cancer	0.0032	0.00388	CbGeAlD
Pimozide—CYP2D6—head—pharynx cancer	0.00312	0.00379	CbGeAlD
Pimozide—CYP2E1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00299	0.0169	CbGpPWpGaD
Pimozide—CYP3A5—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00299	0.0169	CbGpPWpGaD
Pimozide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—pharynx cancer	0.00289	0.0163	CbGpPWpGaD
Pimozide—HRH1—lymph node—pharynx cancer	0.00287	0.00349	CbGeAlD
Pimozide—ABCB1—lymphoid tissue—pharynx cancer	0.00278	0.00338	CbGeAlD
Pimozide—CALM3—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—pharynx cancer	0.00265	0.015	CbGpPWpGaD
Pimozide—CYP2E1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00262	0.0148	CbGpPWpGaD
Pimozide—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00262	0.0148	CbGpPWpGaD
Pimozide—CALM2—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—pharynx cancer	0.00257	0.0145	CbGpPWpGaD
Pimozide—CALM1—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—pharynx cancer	0.00257	0.0145	CbGpPWpGaD
Pimozide—ABCB1—spinal cord—pharynx cancer	0.00252	0.00307	CbGeAlD
Pimozide—CYP3A7—Biological oxidations—CNDP2—pharynx cancer	0.00243	0.0137	CbGpPWpGaD
Pimozide—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00231	0.013	CbGpPWpGaD
Pimozide—ABCB1—head—pharynx cancer	0.00224	0.00273	CbGeAlD
Pimozide—CYP3A7—Biological oxidations—ADH7—pharynx cancer	0.0022	0.0124	CbGpPWpGaD
Pimozide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—pharynx cancer	0.00215	0.0122	CbGpPWpGaD
Pimozide—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00212	0.012	CbGpPWpGaD
Pimozide—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00203	0.0114	CbGpPWpGaD
Pimozide—CYP3A7—Biological oxidations—ADH1B—pharynx cancer	0.00192	0.0109	CbGpPWpGaD
Pimozide—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00186	0.0105	CbGpPWpGaD
Pimozide—CYP1A2—Phase II conjugation—CNDP2—pharynx cancer	0.00181	0.0102	CbGpPWpGaD
Pimozide—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0018	0.0102	CbGpPWpGaD
Pimozide—CYP2E1—Biological oxidations—CNDP2—pharynx cancer	0.00176	0.00993	CbGpPWpGaD
Pimozide—CYP3A5—Biological oxidations—CNDP2—pharynx cancer	0.00175	0.00991	CbGpPWpGaD
Pimozide—CYP2E1—Biological oxidations—ADH7—pharynx cancer	0.00159	0.00898	CbGpPWpGaD
Pimozide—CYP3A5—Biological oxidations—ADH7—pharynx cancer	0.00159	0.00897	CbGpPWpGaD
Pimozide—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00158	0.00892	CbGpPWpGaD
Pimozide—ABCB1—lymph node—pharynx cancer	0.00157	0.00191	CbGeAlD
Pimozide—CALM3—BCR signaling pathway—CD79A—pharynx cancer	0.00154	0.00871	CbGpPWpGaD
Pimozide—CALM2—BCR signaling pathway—CD79A—pharynx cancer	0.00149	0.00843	CbGpPWpGaD
Pimozide—CALM1—BCR signaling pathway—CD79A—pharynx cancer	0.00149	0.00843	CbGpPWpGaD
Pimozide—CYP2E1—Biological oxidations—ADH1B—pharynx cancer	0.00139	0.00788	CbGpPWpGaD
Pimozide—CYP3A5—Biological oxidations—ADH1B—pharynx cancer	0.00139	0.00786	CbGpPWpGaD
Pimozide—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00139	0.00785	CbGpPWpGaD
Pimozide—CYP2C19—Biological oxidations—CNDP2—pharynx cancer	0.00136	0.00766	CbGpPWpGaD
Pimozide—CYP2D6—Biological oxidations—CNDP2—pharynx cancer	0.00125	0.00705	CbGpPWpGaD
Pimozide—CYP2C19—Biological oxidations—ADH7—pharynx cancer	0.00123	0.00693	CbGpPWpGaD
Pimozide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00122	0.00688	CbGpPWpGaD
Pimozide—CYP2D6—Biological oxidations—ADH7—pharynx cancer	0.00113	0.00638	CbGpPWpGaD
Pimozide—CYP2C19—Biological oxidations—ADH1B—pharynx cancer	0.00108	0.00608	CbGpPWpGaD
Pimozide—CYP1A2—Biological oxidations—CNDP2—pharynx cancer	0.00106	0.00597	CbGpPWpGaD
Pimozide—CYP2D6—Biological oxidations—ADH1B—pharynx cancer	0.000989	0.00559	CbGpPWpGaD
Pimozide—CYP1A2—Biological oxidations—ADH7—pharynx cancer	0.000956	0.0054	CbGpPWpGaD
Pimozide—CALM3—Carbohydrate metabolism—B4GALT5—pharynx cancer	0.000954	0.00539	CbGpPWpGaD
Pimozide—CALM2—Carbohydrate metabolism—B4GALT5—pharynx cancer	0.000923	0.00522	CbGpPWpGaD
Pimozide—CALM1—Carbohydrate metabolism—B4GALT5—pharynx cancer	0.000923	0.00522	CbGpPWpGaD
Pimozide—CALM3—EGFR interacts with phospholipase C-gamma—EGFR—pharynx cancer	0.000845	0.00477	CbGpPWpGaD
Pimozide—CYP1A2—Biological oxidations—ADH1B—pharynx cancer	0.000838	0.00474	CbGpPWpGaD
Pimozide—CALM3—PLCG1 events in ERBB2 signaling—EGFR—pharynx cancer	0.000826	0.00467	CbGpPWpGaD
Pimozide—CALM2—EGFR interacts with phospholipase C-gamma—EGFR—pharynx cancer	0.000817	0.00462	CbGpPWpGaD
Pimozide—CALM1—EGFR interacts with phospholipase C-gamma—EGFR—pharynx cancer	0.000817	0.00462	CbGpPWpGaD
Pimozide—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.000816	0.00461	CbGpPWpGaD
Pimozide—CALM1—PLCG1 events in ERBB2 signaling—EGFR—pharynx cancer	0.000799	0.00451	CbGpPWpGaD
Pimozide—CALM2—PLCG1 events in ERBB2 signaling—EGFR—pharynx cancer	0.000799	0.00451	CbGpPWpGaD
Pimozide—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.000738	0.00417	CbGpPWpGaD
Pimozide—CALM3—B Cell Activation—CD79A—pharynx cancer	0.000656	0.00371	CbGpPWpGaD
Pimozide—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.000647	0.00365	CbGpPWpGaD
Pimozide—CALM2—B Cell Activation—CD79A—pharynx cancer	0.000635	0.00359	CbGpPWpGaD
Pimozide—CALM1—B Cell Activation—CD79A—pharynx cancer	0.000635	0.00359	CbGpPWpGaD
Pimozide—CACNA1G—Axon guidance—EGFR—pharynx cancer	0.000551	0.00311	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—CNDP2—pharynx cancer	0.000415	0.00235	CbGpPWpGaD
Pimozide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.000411	0.00232	CbGpPWpGaD
Pimozide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.000411	0.00232	CbGpPWpGaD
Pimozide—CACNA1G—Developmental Biology—EGFR—pharynx cancer	0.000393	0.00222	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—ADH7—pharynx cancer	0.000375	0.00212	CbGpPWpGaD
Pimozide—CALM3—Alzheimers Disease—TP53—pharynx cancer	0.00037	0.00209	CbGpPWpGaD
Pimozide—CALM2—Alzheimers Disease—TP53—pharynx cancer	0.000358	0.00202	CbGpPWpGaD
Pimozide—CALM1—Alzheimers Disease—TP53—pharynx cancer	0.000358	0.00202	CbGpPWpGaD
Pimozide—CALM3—ErbB1 downstream signaling—EGFR—pharynx cancer	0.000351	0.00198	CbGpPWpGaD
Pimozide—CALM2—ErbB1 downstream signaling—EGFR—pharynx cancer	0.000339	0.00192	CbGpPWpGaD
Pimozide—CALM1—ErbB1 downstream signaling—EGFR—pharynx cancer	0.000339	0.00192	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—ADH1B—pharynx cancer	0.000329	0.00186	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—B4GALT5—pharynx cancer	0.000315	0.00178	CbGpPWpGaD
Pimozide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—pharynx cancer	0.000314	0.00177	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—CNDP2—pharynx cancer	0.000301	0.0017	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—CNDP2—pharynx cancer	0.0003	0.0017	CbGpPWpGaD
Pimozide—CALM3—Metabolism—CNDP2—pharynx cancer	0.000299	0.00169	CbGpPWpGaD
Pimozide—CALM1—Metabolism—CNDP2—pharynx cancer	0.000289	0.00163	CbGpPWpGaD
Pimozide—CALM2—Metabolism—CNDP2—pharynx cancer	0.000289	0.00163	CbGpPWpGaD
Pimozide—DRD3—Circadian rythm related genes—TP53—pharynx cancer	0.00028	0.00158	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—ADH7—pharynx cancer	0.000272	0.00154	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—ADH7—pharynx cancer	0.000271	0.00153	CbGpPWpGaD
Pimozide—CALM3—Disease—B4GALT5—pharynx cancer	0.00027	0.00153	CbGpPWpGaD
Pimozide—CALM3—Metabolism—ADH7—pharynx cancer	0.00027	0.00153	CbGpPWpGaD
Pimozide—CALM3—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.000265	0.0015	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—CD79A—pharynx cancer	0.000265	0.00149	CbGpPWpGaD
Pimozide—CALM1—Disease—B4GALT5—pharynx cancer	0.000262	0.00148	CbGpPWpGaD
Pimozide—CALM2—Disease—B4GALT5—pharynx cancer	0.000262	0.00148	CbGpPWpGaD
Pimozide—CALM1—Metabolism—ADH7—pharynx cancer	0.000261	0.00148	CbGpPWpGaD
Pimozide—CALM2—Metabolism—ADH7—pharynx cancer	0.000261	0.00148	CbGpPWpGaD
Pimozide—CALM2—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.000256	0.00145	CbGpPWpGaD
Pimozide—CALM1—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.000256	0.00145	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—CD79A—pharynx cancer	0.000256	0.00145	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—CD79A—pharynx cancer	0.000256	0.00145	CbGpPWpGaD
Pimozide—CALM3—Downstream signal transduction—EGFR—pharynx cancer	0.000249	0.00141	CbGpPWpGaD
Pimozide—CALM3—Signaling by FGFR—EGFR—pharynx cancer	0.000248	0.0014	CbGpPWpGaD
Pimozide—CALM3—Signaling by ERBB2—EGFR—pharynx cancer	0.000247	0.00139	CbGpPWpGaD
Pimozide—CALM3—DAP12 signaling—EGFR—pharynx cancer	0.000246	0.00139	CbGpPWpGaD
Pimozide—CALM2—Downstream signal transduction—EGFR—pharynx cancer	0.000241	0.00136	CbGpPWpGaD
Pimozide—CALM1—Downstream signal transduction—EGFR—pharynx cancer	0.000241	0.00136	CbGpPWpGaD
Pimozide—CALM2—Signaling by FGFR—EGFR—pharynx cancer	0.00024	0.00136	CbGpPWpGaD
Pimozide—CALM1—Signaling by FGFR—EGFR—pharynx cancer	0.00024	0.00136	CbGpPWpGaD
Pimozide—CALM1—Signaling by ERBB2—EGFR—pharynx cancer	0.000239	0.00135	CbGpPWpGaD
Pimozide—CALM2—Signaling by ERBB2—EGFR—pharynx cancer	0.000239	0.00135	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—ADH1B—pharynx cancer	0.000238	0.00135	CbGpPWpGaD
Pimozide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.000238	0.00135	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—ADH1B—pharynx cancer	0.000238	0.00134	CbGpPWpGaD
Pimozide—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.000238	0.00134	CbGpPWpGaD
Pimozide—CALM1—DAP12 signaling—EGFR—pharynx cancer	0.000237	0.00134	CbGpPWpGaD
Pimozide—CALM2—DAP12 signaling—EGFR—pharynx cancer	0.000237	0.00134	CbGpPWpGaD
Pimozide—CALM3—Metabolism—ADH1B—pharynx cancer	0.000237	0.00134	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—CNDP2—pharynx cancer	0.000232	0.00131	CbGpPWpGaD
Pimozide—CALM3—DAP12 interactions—EGFR—pharynx cancer	0.000231	0.00131	CbGpPWpGaD
Pimozide—CALM3—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000231	0.00131	CbGpPWpGaD
Pimozide—CALM3—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000231	0.00131	CbGpPWpGaD
Pimozide—CALM2—Metabolism—ADH1B—pharynx cancer	0.000229	0.00129	CbGpPWpGaD
Pimozide—CALM1—Metabolism—ADH1B—pharynx cancer	0.000229	0.00129	CbGpPWpGaD
Pimozide—CALM3—Signaling by EGFR—EGFR—pharynx cancer	0.000229	0.00129	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—B4GALT5—pharynx cancer	0.000228	0.00129	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—B4GALT5—pharynx cancer	0.000227	0.00128	CbGpPWpGaD
Pimozide—CALM3—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000227	0.00128	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—CNDP2—pharynx cancer	0.000226	0.00128	CbGpPWpGaD
Pimozide—CALM3—Metabolism—B4GALT5—pharynx cancer	0.000226	0.00128	CbGpPWpGaD
Pimozide—CALM3—Signaling by PDGF—EGFR—pharynx cancer	0.000226	0.00128	CbGpPWpGaD
Pimozide—CALM1—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000223	0.00126	CbGpPWpGaD
Pimozide—CALM1—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000223	0.00126	CbGpPWpGaD
Pimozide—CALM2—DAP12 interactions—EGFR—pharynx cancer	0.000223	0.00126	CbGpPWpGaD
Pimozide—CALM2—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000223	0.00126	CbGpPWpGaD
Pimozide—CALM1—DAP12 interactions—EGFR—pharynx cancer	0.000223	0.00126	CbGpPWpGaD
Pimozide—CALM2—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000223	0.00126	CbGpPWpGaD
Pimozide—CALM1—Signaling by EGFR—EGFR—pharynx cancer	0.000221	0.00125	CbGpPWpGaD
Pimozide—CALM2—Signaling by EGFR—EGFR—pharynx cancer	0.000221	0.00125	CbGpPWpGaD
Pimozide—CALM1—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000219	0.00124	CbGpPWpGaD
Pimozide—CALM2—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000219	0.00124	CbGpPWpGaD
Pimozide—CALM1—Metabolism—B4GALT5—pharynx cancer	0.000219	0.00124	CbGpPWpGaD
Pimozide—CALM2—Metabolism—B4GALT5—pharynx cancer	0.000219	0.00124	CbGpPWpGaD
Pimozide—CALM2—Signaling by PDGF—EGFR—pharynx cancer	0.000219	0.00123	CbGpPWpGaD
Pimozide—CALM1—Signaling by PDGF—EGFR—pharynx cancer	0.000219	0.00123	CbGpPWpGaD
Pimozide—DRD2—Circadian rythm related genes—TP53—pharynx cancer	0.000214	0.00121	CbGpPWpGaD
Pimozide—CALM3—B Cell Activation—EGFR—pharynx cancer	0.000214	0.00121	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.000213	0.00121	CbGpPWpGaD
Pimozide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00021	0.00119	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ADH7—pharynx cancer	0.00021	0.00119	CbGpPWpGaD
Pimozide—CALM1—B Cell Activation—EGFR—pharynx cancer	0.000207	0.00117	CbGpPWpGaD
Pimozide—CALM2—B Cell Activation—EGFR—pharynx cancer	0.000207	0.00117	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—ADH7—pharynx cancer	0.000205	0.00116	CbGpPWpGaD
Pimozide—CALM3—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000205	0.00116	CbGpPWpGaD
Pimozide—CALM1—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000198	0.00112	CbGpPWpGaD
Pimozide—CALM2—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000198	0.00112	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ADH7—pharynx cancer	0.000193	0.00109	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ADH1B—pharynx cancer	0.000184	0.00104	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.000181	0.00102	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—ADH1B—pharynx cancer	0.00018	0.00101	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—B4GALT5—pharynx cancer	0.000176	0.000993	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.000172	0.00097	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.000169	0.000956	CbGpPWpGaD
Pimozide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000165	0.000931	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ADH7—pharynx cancer	0.000163	0.000924	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.000162	0.000914	CbGpPWpGaD
Pimozide—CALM3—Immune System—CD79A—pharynx cancer	0.00016	0.000907	CbGpPWpGaD
Pimozide—CALM3—Signaling by NGF—EGFR—pharynx cancer	0.000157	0.000889	CbGpPWpGaD
Pimozide—CALM1—Immune System—CD79A—pharynx cancer	0.000155	0.000877	CbGpPWpGaD
Pimozide—CALM2—Immune System—CD79A—pharynx cancer	0.000155	0.000877	CbGpPWpGaD
Pimozide—CALM2—Signaling by NGF—EGFR—pharynx cancer	0.000152	0.00086	CbGpPWpGaD
Pimozide—CALM1—Signaling by NGF—EGFR—pharynx cancer	0.000152	0.00086	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—CDH1—pharynx cancer	0.000147	0.000833	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.000143	0.00081	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—CDH1—pharynx cancer	0.000143	0.000805	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—CDH1—pharynx cancer	0.000143	0.000805	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000139	0.000788	CbGpPWpGaD
Pimozide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000138	0.000781	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.000137	0.000774	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000126	0.000713	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000111	0.000625	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—EGFR—pharynx cancer	0.000109	0.000618	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—EGFR—pharynx cancer	0.000108	0.000609	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000106	0.000597	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—EGFR—pharynx cancer	9.24e-05	0.000522	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—EGFR—pharynx cancer	9.15e-05	0.000517	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—EGFR—pharynx cancer	8.97e-05	0.000507	CbGpPWpGaD
Pimozide—CALM3—Immune System—CDH1—pharynx cancer	8.94e-05	0.000505	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—EGFR—pharynx cancer	8.68e-05	0.00049	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—EGFR—pharynx cancer	8.68e-05	0.00049	CbGpPWpGaD
Pimozide—CALM2—Immune System—CDH1—pharynx cancer	8.65e-05	0.000489	CbGpPWpGaD
Pimozide—CALM1—Immune System—CDH1—pharynx cancer	8.65e-05	0.000489	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—EGFR—pharynx cancer	8.62e-05	0.000487	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—TP53—pharynx cancer	8.37e-05	0.000473	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—EGFR—pharynx cancer	8.34e-05	0.000471	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—EGFR—pharynx cancer	8.34e-05	0.000471	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—CCND1—pharynx cancer	8.23e-05	0.000465	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—CCND1—pharynx cancer	8.11e-05	0.000458	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—TP53—pharynx cancer	8.1e-05	0.000457	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—TP53—pharynx cancer	8.1e-05	0.000457	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—EGFR—pharynx cancer	7.98e-05	0.000451	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—EGFR—pharynx cancer	7e-05	0.000396	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CCND1—pharynx cancer	6.96e-05	0.000393	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CCND1—pharynx cancer	6.89e-05	0.000389	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—EGFR—pharynx cancer	6.89e-05	0.000389	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—EGFR—pharynx cancer	6.88e-05	0.000389	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—EGFR—pharynx cancer	6.77e-05	0.000382	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—EGFR—pharynx cancer	6.46e-05	0.000365	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—EGFR—pharynx cancer	6.37e-05	0.00036	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CCND1—pharynx cancer	6.01e-05	0.000339	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—EGFR—pharynx cancer	5.72e-05	0.000323	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—EGFR—pharynx cancer	5.53e-05	0.000313	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—EGFR—pharynx cancer	5.53e-05	0.000313	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—EGFR—pharynx cancer	5.46e-05	0.000308	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TP53—pharynx cancer	5.42e-05	0.000306	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—EGFR—pharynx cancer	5.41e-05	0.000306	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TP53—pharynx cancer	5.35e-05	0.000302	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CCND1—pharynx cancer	5.27e-05	0.000298	CbGpPWpGaD
Pimozide—CALM3—Immune System—EGFR—pharynx cancer	5.23e-05	0.000295	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CCND1—pharynx cancer	5.19e-05	0.000293	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CCND1—pharynx cancer	5.18e-05	0.000293	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CCND1—pharynx cancer	5.09e-05	0.000288	CbGpPWpGaD
Pimozide—CALM2—Immune System—EGFR—pharynx cancer	5.06e-05	0.000286	CbGpPWpGaD
Pimozide—CALM1—Immune System—EGFR—pharynx cancer	5.06e-05	0.000286	CbGpPWpGaD
Pimozide—CALM3—Disease—EGFR—pharynx cancer	4.83e-05	0.000273	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—EGFR—pharynx cancer	4.71e-05	0.000266	CbGpPWpGaD
Pimozide—CALM2—Disease—EGFR—pharynx cancer	4.67e-05	0.000264	CbGpPWpGaD
Pimozide—CALM1—Disease—EGFR—pharynx cancer	4.67e-05	0.000264	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—pharynx cancer	4.58e-05	0.000259	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—pharynx cancer	4.54e-05	0.000257	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCND1—pharynx cancer	4.31e-05	0.000243	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCND1—pharynx cancer	4.17e-05	0.000235	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCND1—pharynx cancer	4.17e-05	0.000235	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—EGFR—pharynx cancer	4.14e-05	0.000234	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EGFR—pharynx cancer	4.07e-05	0.00023	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EGFR—pharynx cancer	4.06e-05	0.00023	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EGFR—pharynx cancer	4e-05	0.000226	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—pharynx cancer	3.96e-05	0.000224	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—pharynx cancer	3.47e-05	0.000196	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—pharynx cancer	3.42e-05	0.000193	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—pharynx cancer	3.41e-05	0.000193	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EGFR—pharynx cancer	3.38e-05	0.000191	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—pharynx cancer	3.36e-05	0.00019	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EGFR—pharynx cancer	3.27e-05	0.000185	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EGFR—pharynx cancer	3.27e-05	0.000185	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—pharynx cancer	2.84e-05	0.00016	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—pharynx cancer	2.74e-05	0.000155	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—pharynx cancer	2.74e-05	0.000155	CbGpPWpGaD
